Amedisys Inc (AMED) is Downgraded by Mizuho to Neutral, Lowers Price Target to $ 55

Amedisys Inc (AMED) was Downgraded by Mizuho to ” Neutral” while Lowering the Price Target of the company shares to $ 55 from a previous price target of $57 . Earlier the firm had a rating of “Buy ” on the company shares. Mizuho advised their investors in a research report released on Aug 3, 2016.

Many Wall Street Analysts have commented on Amedisys Inc. Company shares were Reiterated by RBC Capital Mkts on May 6, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 48 from a previous price target of $41 .

On the company’s financial health, Amedisys Inc reported $0.40 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Mar 8, 2016. Analyst had a consensus of $0.35. The company had revenue of $338.37 million for the quarter, compared to analysts expectations of $322.02 million. The company’s revenue was up 12.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.27 EPS.

Amedisys Inc closed down -1.22 points or -2.22% at $53.78 with 5,46,804 shares getting traded on Tusday. Post opening the session at $54.16, the shares hit an intraday low of $51.44 and an intraday high of $54.95 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.

In a different news, on May 17, 2016, Bruce D Perkins (director) purchased 1,000 shares at $50.21 per share price. According to the SEC, on May 13, 2016, Scott G Ginn (officer ) sold 6,000 shares at $51.65 per share price. On Aug 19, 2015, Donald A Washburn (director) sold 20,000 shares at $45.51 per share price, according to the Form-4 filing with the securities and exchange commission.

Amedisys Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360000 patients each year. The Company has care network across 34 states. As of December 31 2014 it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Company’s home health segment delivers a range of services in the homes of individuals who may be recovering from surgery have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families.

Amedisys Inc

Leave a Reply

Amedisys Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amedisys Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.